Drugs / NIC002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01280968 | Dec 2010 → Sep 2012 | nicotine dependence | Alexey Mukhin | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00736047 Comparator | Aug 2008 → Oct 2009 | — | Novartis | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NIC002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01280968 ↗ |
| Modality | Vaccine | “100µg NIC002 Vaccine” NCT00736047 ↗ |
| Route | Subcutaneous | “Repeated s.c Administrations” NCT00736047 ↗ |